CASP9 and breast carcinoma: Similarly, cleaved caspase-9 and cleaved PARP was significantly increased in PSD-A treated MCF-7 cells, however, caspase-3 was not detected during western blotting analysis as MCF-7 human breast cancer cells are deficient of caspase-3 (Figure 2E).